Alaunos Therapeutics | ZIOP - Ebitda


Alaunos Therapeutics reported $-21.02M in EBITDA for its fiscal quarter ending in March of 2021.





Ebitda Change Date
Alaunos Therapeutics USD -21.02M 1.33M Mar/2021
Amgen USD 5.8B 1.25B Sep/2026
AstraZeneca USD 7.46B 2.3B Sep/2026
Baxter International USD 474M 165M Jun/2026
Biogen USD 450.8M 198.9M Jun/2026
Bioline Rx USD -4.05M 1.8M Jun/2026
Bristol-Myers Squibb USD 3.48B 1.6B Sep/2026
Celltrion KRW 25.72B 6.08B Jun/2026
Corcept Therapeutics USD 42.16M 91.17M Jun/2026
Cspc Pharmaceutical CNY 2.19B 21.88M Dec/2024
Curis USD -12.3M 231K Sep/2023
Deva Holding AS TRY 882.9M 201.7M Sep/2023
Dianthus Therapeutics USD -61.38M 14.92M Jun/2026
Divis Laboratories Ltd INR 12.62B 3.28B Jun/2026
Gilead Sciences USD -9.31B 12.82B Jun/2026
GlaxoSmithKline GBP 3.51B 734M Jun/2026
Incyte USD 778.57M 410.6M Jun/2026
Intrexon USD -24.7M 2.92M Jun/2024
Ionis Pharmaceuticals USD -64.53M 135.49M Mar/2026
J&J USD 8.99B 721M Jun/2026
Kangmei Pharma CNY -12.72M 30.02M Mar/2026
Karyopharm Therapeutics USD -26.2M 1.83M Sep/2024
Knight Therapeutics CAD 24.45M 3.46M Dec/2025
Laboratorios Farma EUR 34.94M 102.95M Jun/2025
Malin Corporation EUR -1.1M 200K Dec/2024
Medical Developments International AUD 1.78M 3.78M Dec/2024
Merck USD 1.42B 2.97B Jun/2026
Neuren Pharmaceuticals AUD 11.14M 165.56M Dec/2025
Novartis USD 8.62B 2.14B Sep/2026
Organigram Holdings CAD 15.45M 20.21M Jun/2026
Pfizer USD 6.36B 350M Sep/2026
Pharma Mar EUR 9.63M 8.93M Sep/2026
PTC Therapeutics USD 161.9M 99.92M Jun/2026
Qiagen NV USD 219.78M 12.13M Sep/2026
Regeneron Pharmaceuticals USD 1.66B 695.2M Jun/2026
Roche Holding CHF 13.43B 744M Jun/2026
Sartorius EUR 279.9M 600K Sep/2026
Sino Biopharmaceutical CNY 2.59B 1.57B Dec/2024
TG Therapeutics USD 26.9M 1.21M Jun/2026
Tilray USD 8.36M 1.82M Sep/2025
Zealand Pharma A/S -379M 348.47M Mar/2026
Zhangzhou Pientzehuang Pharmaceutical CNY 419.24M 463.46M Jun/2026